Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul-Aug;74(4):566-70.
doi: 10.1016/s1808-8694(15)30604-2.

Assessment of clinical and therapeutic factors in patients with nasopharyngeal undifferentiated carcinoma

Helma Maria Chedid  1 , Sergio Altino Franzi, Rogério Aparecido Dedivitis
Affiliations

Assessment of clinical and therapeutic factors in patients with nasopharyngeal undifferentiated carcinoma

Helma Maria Chedid et al. Braz J Otorhinolaryngol. 2008 Jul-Aug.

Abstract

The nasopharyngeal carcinoma (NPC) is a rare cancer with a high incidence in Southern Asia.

Aim: To study the demographic, clinical, therapeutic, and prognostic factors of nasopharyngeal undifferentiated carcinoma in a reference service.

Materials and methods: A retrospective study was made of 46 patients from January 1998 to August 2000. The patients had no previous treatment and did not present any evidence of synchronous tumors or distance metastases.

Results: The age ranged from 14 to 78 years (mean = 46 years); 35 (76%) patients were male. All patients were Caucasian or African-Brazilian. The onset of initial symptoms ranged from 1 to 48 months (mean = 7 months); 47% of the subjects smoked tobacco and 33% consumed alcoholic beverages. A lump in the neck was the most frequent symptom (34 patients). Twenty-two patients were clinically staged as T1/T2 and 24 patients as T3/T4; 24 patients were classified as N2, and 16 patients were staged as N3. Curative treatment consisted of radiotherapy and simultaneous chemotherapy in clinical stages III and IV. Of 27 patients that were monitored, 52% were alive with no evidence of disease after three years.

Conclusion: All patients were in advanced clinical stages of the disease. The three-year disease-free survival rate was 52%.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of disease-free survival of patients with undifferentiated nasopharyngeal carcinomas.
See this image and copyright information in PMC

References

    1. Cooper JS, Cohen R, Stevens RE. A comparison of staging systems for nasopharyngeal carcinoma. Cancer. 1998;83:213–219. - PubMed
    1. Dickson RI. Nasopharymgeal carcinoma: an evaluation of 209 patients. Laryngoscope. 1981;91(3):333–354. - PubMed
    1. Marks JE, Philips JL, Menck HR. The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer. 1998;83:582–588. - PubMed
    1. Farrow DC, Vaughan TL, Berwick M, Lynch CF, Swanson CM, Lyon JL. Diet and nasopharyngeal cancer in a low-risk population. Int J Cancer. 1998;78:675–679. - PubMed
    1. Ho JHC. Nasopharyngeal carcinoma. Adv Cancer Res. 1972;15:57–92. - PubMed

Uncited Reference

    1. Wei WI, Ho WK, Cheng AC, Wu X, Li GK, Nicholls J, et al. Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study. Arch Otolaryngol Head Neck Surg. 2001;127(12):1457–1462. - PubMed
    1. Spano JP, Bresson P, Atlan D, Bourhis J, Pignon JP, Esteban C, et al. Nasopharyngeal carcinoma: an update. Eur J Cancer. 2003;39(5):2124–2135. - PubMed
    1. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–2054. - PubMed

MeSH terms

LinkOut - more resources